Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) - Total Liabilities
Based on the latest financial reports, Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has total liabilities worth CN¥571.21 Million CNY (≈ $83.59 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shenzhen Bioeasy Biotechnology Co. Ltd. cash conversion from operations to assess how effectively this company generates cash.
Shenzhen Bioeasy Biotechnology Co. Ltd. - Total Liabilities Trend (2016–2024)
This chart illustrates how Shenzhen Bioeasy Biotechnology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Shenzhen Bioeasy Biotechnology Co. Ltd. to evaluate the company's liquid asset resilience ratio.
Shenzhen Bioeasy Biotechnology Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shenzhen Bioeasy Biotechnology Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sayona Mining Limited American Depository Shares
NASDAQ:ELVR
|
USA | $177.27 Million |
|
VersaBank
NASDAQ:VBNK
|
USA | $5.61 Billion |
|
Village Super Market Inc
NASDAQ:VLGEA
|
USA | $510.58 Million |
|
Jiangsu Huifeng Agrochemical Co Ltd
SHE:002496
|
China | CN¥987.73 Million |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
China | CN¥1.81 Billion |
|
Shahe Industry Co Ltd
SHE:000014
|
China | CN¥669.93 Million |
|
Beijing Kaiwen Education Technology Co Ltd
SHE:002659
|
China | CN¥845.23 Million |
|
Chongqing Sansheng Building Materials Co Ltd
SHE:002742
|
China | CN¥956.46 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Shenzhen Bioeasy Biotechnology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shenzhen Bioeasy Biotechnology Co. Ltd. market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shenzhen Bioeasy Biotechnology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2024)
The table below shows the annual total liabilities of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥586.92 Million ≈ $85.89 Million |
+15.62% |
| 2023-12-31 | CN¥507.61 Million ≈ $74.28 Million |
+59.75% |
| 2022-12-31 | CN¥317.75 Million ≈ $46.50 Million |
+54.29% |
| 2021-12-31 | CN¥205.94 Million ≈ $30.14 Million |
+98.20% |
| 2020-12-31 | CN¥103.90 Million ≈ $15.20 Million |
+13.75% |
| 2019-12-31 | CN¥91.35 Million ≈ $13.37 Million |
+23.08% |
| 2018-12-31 | CN¥74.22 Million ≈ $10.86 Million |
+25.38% |
| 2017-12-31 | CN¥59.19 Million ≈ $8.66 Million |
-12.73% |
| 2016-12-31 | CN¥67.83 Million ≈ $9.93 Million |
-- |
About Shenzhen Bioeasy Biotechnology Co. Ltd.
Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatm… Read more